scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41379-018-0131-6 |
P698 | PubMed publication ID | 30237525 |
P50 | author | Charles Y. Chiu | Q30505278 |
Kuang-Yu Jen | Q59691146 | ||
Kirk D Jones | Q74054359 | ||
Soo-Jin Cho | Q80421609 | ||
Eliah R Shamir | Q82567506 | ||
Sarah E Umetsu | Q88161586 | ||
Melike Pekmezci | Q88683629 | ||
P2093 | author name string | Sanjay Kakar | |
Scot Federman | |||
Emily Bergsland | |||
Grace E Kim | |||
Nancy M Joseph | |||
Gregor Krings | |||
W Patrick Devine | |||
Tara A Saunders | |||
P2860 | cites work | DELLY: structural variant discovery by integrated paired-end and split-read analysis | Q24605418 |
Gastroenteropancreatic high-grade neuroendocrine carcinoma | Q26998392 | ||
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. | Q27853379 | ||
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication | Q28248149 | ||
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
Fast and accurate long-read alignment with Burrows-Wheeler transform | Q29547193 | ||
A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
Papillomaviruses and cancer: from basic studies to clinical application | Q29614745 | ||
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer | Q29615679 | ||
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads | Q29617402 | ||
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness | Q33757149 | ||
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. | Q34202062 | ||
Human papillomavirus is not associated with colorectal cancer in a large international study | Q34723700 | ||
Human papillomavirus-related small cell carcinoma of the oropharynx | Q35354701 | ||
Neuroendocrine carcinomas of the colon and rectum. | Q35713624 | ||
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. | Q35995950 | ||
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. | Q36479375 | ||
RB and cell cycle progression | Q36579245 | ||
Comprehensive genomic profiles of small cell lung cancer | Q36883530 | ||
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer | Q36951751 | ||
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas | Q37182620 | ||
The evolving landscape of neuroendocrine tumors | Q38079850 | ||
The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas | Q38079856 | ||
Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System | Q38381324 | ||
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine | Q38605559 | ||
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer | Q38768101 | ||
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas | Q38853033 | ||
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas | Q39036665 | ||
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. | Q39430735 | ||
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease | Q40808084 | ||
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study | Q43905778 | ||
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology | Q46864354 | ||
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases. | Q47358369 | ||
Biology and evolution of poorly differentiated neuroendocrine tumors | Q48320507 | ||
HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior | Q48678604 | ||
Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling | Q49283122 | ||
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas. | Q50652349 | ||
Whole-genome landscape of pancreatic neuroendocrine tumours. | Q51137102 | ||
Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor. | Q52664181 | ||
Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer | Q67912069 | ||
Detection of human papillomavirus in small cell carcinomas of the anus and rectum | Q83983234 | ||
The genetics of neuroendocrine tumors | Q86078968 | ||
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification | Q89256994 | ||
P433 | issue | 2 | |
P921 | main subject | neuroendocrine carcinoma | Q18554913 |
P304 | page(s) | 290-305 | |
P577 | publication date | 2018-09-20 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma | |
P478 | volume | 32 |
Q92132897 | A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas |
Q90604719 | An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin |
Q90706027 | Cancer stem cells in esophageal squamous cell cancer |
Q64949324 | Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review. |
Q98665207 | Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine |
Q91752429 | The broken cycle: E2F dysfunction in cancer |